Michael Kron

Michael Kron

Auto-generated profile, based on publicly available information

Michael Kron

Department of Infectious Disease, Froedtert and Medical College of Wisconsin , Milwaukee, Wisconsin

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YCYantao Chen
Yantao Chen
RRRen Ren
Ren Ren
HPHaihui Pu
Haihui Pu
XGXiaoru Guo
Xiaoru Guo
JCJingbo Chang
Jingbo Chang
JCJunhong Chen
Junhong Chen
The Ebola virus transmits a highly contagious, frequently fatal human disease for which there is no specific antiviral treatment. Therefore, rapid, accurate, and early diagnosis of Ebola virus disease (EVD) is critical to public health containment efforts, particularly in developing countries where resources are few and EVD is endemic. We have developed a reduced graphene oxide-based field-effect transistor method for real-time detection of the Ebola virus antigen. This method uses the attractive semiconductor characteristics of graphene-based material, and instantaneously yields highly sensitive and specific detection of Ebola glycoprotein. The feasibility of this method for clinical application in point-of-care technology is evaluated using Ebola glycoprotein suspended in diluted PBS buffer, human serum, and plasma. These results demonstrate the successful fabrication of a promising field-effect transistor biosensor for EVD diagnosis.

12 September 2012 in Organic Letters
Verified
Journal Article
Closed access
ZYZhiguo Yu
Zhiguo Yu
SVSanja Vodanovic-Jankovic
Sanja Vodanovic-Jankovic
MKMichael Kron
Michael Kron
BSBen Shen
Ben Shen

15 March 2011 in Organic Letters
Verified
Journal Article
Closed access
ZYZhiguo Yu
Zhiguo Yu
SVSanja Vodanovic-Jankovic
Sanja Vodanovic-Jankovic
NLNathan Ledeboer
Nathan Ledeboer
SHSheng-Xiong Huang
Sheng-Xiong Huang
SRScott R. Rajski
Scott R. Rajski
BSBen Shen
Ben Shen

1 February 2013 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
MKMichael A. Kron
Michael A. Kron
AMAhmed Metwali
Ahmed Metwali
SVSanja Vodanovic-Jankovic
Sanja Vodanovic-Jankovic
DEDavid Elliott
David Elliott
The therapeutic effects of a controlled parasitic nematode infection on the course of inflammatory bowel disease (IBD) have been demonstrated in both animal and human models. However, the inability of individual well-characterized nematode proteins to recreate these beneficial effects has limited the application of component immunotherapy to human disease. The nematodes that cause chronic human lymphatic filariasis, Brugia malayi and Wuchereria bancrofti , are among the parasites that induce immune suppression. Filarial lymphatic pathology has been shown to involve NF-κB pathway-dependent production of vascular endothelial growth factor (VEGF), and stimulation of VEGF expression has also been reported by interleukin 8 (IL-8) via NF-κB pathways. Previously, we have shown that the filarial asparaginyl-tRNA synthetase (rBmAsnRS) interacts with IL-8 receptors using a combination of extracellular loops that differ from those bound by IL-8. To test the hypothesis that rBmAsnRS might induce an anti-inflammatory effect in vivo , we studied the effects of rBmAsnRS in an established murine colitis model using T-cell transfer mice. T-cell transfer colitis mice treated intraperitoneally with 100 μg of rBmAsnRS four times over 2 weeks showed resolution of cellular infiltration in the colonic mucosa, along with induction of a CD8 + cellular response. In addition, rBmAsnRS induced a rise in IL-10 production from CD3 + and lipopolysaccharide (LPS)- and cytosine phosphate guanosine (CPG)-stimulated splenic cells. In summary, this work demonstrates a novel anti-inflammatory nematode protein, supports the hygiene hypothesis, and supports continued refinement of alternative immunotherapies for treatment of IBD.

1 September 2012 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
MKMichael A. Kron
Michael A. Kron
CWCheng Wang
Cheng Wang
SVSanja Vodanovic-Jankovic
Sanja Vodanovic-Jankovic
OHO.M. Zack Howard
O.M. Zack Howard
LKLeslie A. Kuhn
Leslie A. Kuhn

1 August 1990 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
DSD M Shlaes
D M Shlaes
CCC Currie-McCumber
C Currie-McCumber
AHA Hull
A Hull
IBIrmgard Behlau
Irmgard Behlau
MKM Kron
M Kron
The OHIO-1 beta-lactamase gene was subcloned in a 1.16-kilobase TaqI fragment in the 2.4-kilobase chimeric plasmid pSK04. After directional subcloning into M13, the DNA sequence of this fragment was determined. The results showed an open reading frame of 858 base pairs (bp) encoding a protein of 286 amino acids. The structural gene showed 95, 87, and 60% DNA sequence identity with SHV-1, LEN-1, and TEM-1, respectively, and 93, 85, and 62% predicted amino acid sequence identity, respectively. The 87 bp upstream of the OHIO-1 structural gene had 96% identity with the upstream flanking sequence of SHV-1, including the -35 and -10 consensus sequences and the putative ribosomal binding site. A 223-bp DNA probe derived from a PstI-HaeII fragment in the C-terminal sequence of OHIO-1 had predicted 96, 88, and 61% sequence identity with SHV-1, LEN-1, and TEM-1, respectively. This probe hybridized to SHV-1 and poorly to LEN-1, but not to TEM-1 or a variety of other plasmid-mediated beta-lactamase genes, under stringent conditions. Screening of plasmid DNA derived from 40 ampicillin-resistant clinical isolates by Southern hybridization with the 223-bp probe uncovered no strains encoding OHIO-1. Isoelectric focusing of the same collection did identify two strains producing enzymes resembling SHV-1, however. We have also performed a kinetic comparison of OHIO-1, SHV-1, and TEM-1. OHIO-1 and SHV-1 were indistinguishable from each other but could be distinguished from TEM-1. These data clearly place OHIO-1 within the SHV-1 family of beta-lactamases.